AI, Logistics and the Shifting Future of Drug Distribution in Hungary

Hungaropharma’s logistics operations in Hungary have evolved to rely on artificial intelligence and data-driven coordination rather than physical robotics, particularly in managing ultra-low temperature storage for vaccines. By 2020, the company had already expanded its capacity to store products at minus 70 to minus 90 degrees Celsius, which proved critical for distributing COVID-19 vaccines across Hungary the following year. CEO Judit Füzesi notes that the industry’s progress stems from long-term planning and a global mindset, contrasting with public perceptions of rapid digital transformation. While robotics exist within Hungaropharma’s logistics, they are not humanoid but embedded in planning, forecasting, and inventory systems. Füzesi rejects the adoption of unproven technologies like humanoid robots, citing lack of economic justification and process efficiency. Instead, AI is applied where data is generated, such as forecasting shortages, improving financial planning, and supporting smaller market players. The shift toward AI in pharmaceutical logistics is described as part of a broader digital evolution, not a sudden transformation. Füzesi emphasizes that AI can enhance operations for small and medium-sized enterprises (SMEs) and improve patient relations, but it cannot address all supply chain pressures alone. Challenges like cost inflation and energy risks remain persistent threats to the industry. Hungaropharma’s approach reflects a cautious integration of technology, prioritizing practical applications over speculative advancements. The company’s systems are designed to operate securely and efficiently, with AI playing a key role in data-heavy processes across the supply chain. Füzesi stresses that sustainability in technology adoption means avoiding forced integration of unproven tools, ensuring long-term viability and cost-effectiveness.